Vertex Pharmaceuticals (VRTX)

Depreciation & Amortization

$222.10M

TTM · Period ending: · USD

VRTX logo

VRTX Depreciation & Amortization

Latest reported$222.10M
VRTX TTM Depreciation & Amortization ($2.80M → $222.10M)
High-resolution chart · PNG

VRTX depreciation & amortization history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Vertex Pharmaceuticals Depreciation & Amortization — Trailing twelve months (TTM) (USD)
Period endingDepreciation & Amortization (USD)
10,592,000
9,643,000
9,095,000
8,399,000
7,785,000
7,075,000
6,300,000
5,700,000
5,100,000
4,800,000
4,500,000
4,100,000
4,000,000
3,700,000
3,600,000
3,300,000
3,100,000
3,200,000
3,200,000
3,500,000
3,700,000
3,500,000
3,700,000
3,700,000
3,400,000
3,600,000
3,500,000
3,600,000
3,800,000
4,000,000
3,900,000
3,500,000
3,300,000
3,000,000
2,800,000
2,600,000
2,300,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.